Papilocare Vaginal Gel

Nom de l'organisation

Procare Health Iberia SL

SRN

ES-MF-000001950

Statut du fabricant

Actif

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW018

  If after application you experience discomfort, the use of the product should be discontinued, and the doctor consulted. No data are available on the use of Papilocare® with vaginal contraceptives (e.g., vaginal ring, female condom) so, the use of Papilocare® in women who are using this type of contraceptive is not recommended. Do not use after expiry date on the packaging, the gel may have degraded and not perform as intended. Single use only, re-use may cause risk of cross-infection. Do not use if packaging or seal is compromised or if the product is damaged. Store only at the temperatures stated to avoid degradation of the gel. For HPV induced high-grade squamous intraepithelial lesions (HSIL), Papilocare® may be used only when conservative management is justified according to current clinical guidelines, and always under strict medical supervision. No overdose problems can be expected with the use of Papilocare®. However, there are no studies conducted considering this situation and it is recommended to be used only under strict medical supervision.

Marché principal en Hongrie ; disponible dans 4 pays au total.

Dénomination commerciale

Papilocare Vaginal Gel

Code d'UDI-DI

08436620080290

Basic UDI-DI

B-08436620080290

Numéro de référence/catalogue

-

Entité d'attribution

GS1

Catégorie de risque

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Vaginal Gel

URL des informations complémentaires

https://www.procarehealth.com/

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• U0803VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel